Page last updated: 2024-10-30

metformin and Autoimmune Thrombocytopenia

metformin has been researched along with Autoimmune Thrombocytopenia in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
" Previous reports indicate that ELT is mainly eliminated in the liver, although its pharmacokinetic profile has not yet been clarified in detail."1.37Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent. ( Horikawa, M; Ishiwata, N; Kato, Y; Matsubara, K; Nakamichi, N; Silver, DL; Sugiura, T; Takeuchi, K; Umeda, S, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takeuchi, K1
Sugiura, T1
Umeda, S1
Matsubara, K1
Horikawa, M1
Nakamichi, N1
Silver, DL1
Ishiwata, N1
Kato, Y1

Other Studies

1 other study available for metformin and Autoimmune Thrombocytopenia

ArticleYear
Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:6

    Topics: Animals; Benzoates; Blood Platelets; Cell Line; Dose-Response Relationship, Drug; Hepatocytes; Human

2011